Search

Haresh N Vazir

from Victoria, TX
Age ~55

Haresh Vazir Phones & Addresses

  • 3004 Houston Hwy, Victoria, TX 77901
  • Edna, TX
  • 305 Kern St, Salinas, CA 93905
  • 10528 Caminito Pollo, San Diego, CA 92126
  • 3338 Cowley Way, San Diego, CA 92117
  • Alameda, CA
  • Jackson, TX

Work

Company: Royal inn Mar 2007 Position: Manager

Education

School / High School: University of California, Santa Cruz 1987 to 1994

Industries

Hospitality

Resumes

Resumes

Haresh Vazir Photo 1

Manager

View page
Location:
3004 Houston Hwy, Victoria, TX 77901
Industry:
Hospitality
Work:
ROYAL INN since Mar 2007
manager

Pfizer 1998 - 2001
research associate

PGRD La Jolla 1998 - 2001
Research Associate

Alanex 1998 - 2001
Research Assistant
Education:
University of California, Santa Cruz 1987 - 1994

Business Records

Name / Title
Company / Classification
Phones & Addresses
Haresh Vazir
BHOOMI HIRAL PRIYANSHI LLC
3004 Houston Hwy, Victoria, TX 77901

Publications

Us Patents

Non-Peptide Gnrh Agents, Methods And Intermediates For Their Preparation

View page
US Patent:
7101878, Sep 5, 2006
Filed:
Aug 20, 1999
Appl. No.:
09/763216
Inventors:
Mark Brian Anderson - Orinda CA, US
Haresh N. Vazir - San Diego CA, US
David Robert Luthin - Encinitas CA, US
Genevieve DeGuzman Paderes - San Diego CA, US
Ved P. Pathak - San Diego CA, US
Lance Christopher Christie - Vista CA, US
Yufeng Hong - San Diego CA, US
Eileen Valenzuela Tompkins - Escondido CA, US
Haitao Li - San Diego CA, US
James Faust - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 405/12
C07D 307/68
A61K 31/34
A61K 31/505
A61P 5/04
US Classification:
5142315, 549487, 549488, 514461, 514370, 514336, 514444, 51425505, 514394, 548195, 5483047, 544152, 544405, 546233, 5462847, 546 60
Abstract:
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.

Non-Peptide Gnrh Agents, Methods And Intermediates For Their Preparation

View page
US Patent:
20040010033, Jan 15, 2004
Filed:
Jul 8, 2003
Appl. No.:
10/353160
Inventors:
Mark Anderson - Orinda CA, US
Haresh Vazir - Salinas CA, US
David Luthin - Encinitas CA, US
Genevieve Paderes - San Diego CA, US
Ved Pathak - San Diego CA, US
Lance Christie - Vista CA, US
Yufeng Hong - San Diego CA, US
Eileen Tompkins - Escondido CA, US
Haitao Li - San Diego CA, US
James Faust - Temecula CA, US
Assignee:
Pfizer Inc.
International Classification:
A61K031/34
C07D307/02
US Classification:
514/471000, 549/487000
Abstract:
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.

Non-Peptide Gnrh Agents, Pharmaceutical Compositions, And Methods For Their Use

View page
US Patent:
20040053951, Mar 18, 2004
Filed:
Feb 11, 2003
Appl. No.:
10/364193
Inventors:
Lance Christie - Vista CA, US
Mark Anderson - Orinda CA, US
Jun Feng - Carlsbad CA, US
Yufeng Hong - San Diego CA, US
Ved Pathak - San Diego CA, US
Ranjan Rajapakse - Poway CA, US
Eileen Tompkins - Escondido CA, US
Haresh Vazir - Salinas CA, US
Haitao Li - San Diego CA, US
Assignee:
Pfizer Inc.
International Classification:
A61K031/513
C 07D 4 5/14
US Classification:
514/269000, 544/314000, 544/310000
Abstract:
Non-peptide GnRH agents that inhibit the effect of gonadotropin-releasing hormone are described. Such agents are useful for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated.
Haresh N Vazir from Victoria, TX, age ~55 Get Report